Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis
about
Magnetic resonance frequency shifts during acute MS lesion formationIron in Multiple Sclerosis and Its Noninvasive Imaging with Quantitative Susceptibility MappingSeven-tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory processOn the role of neuronal magnetic susceptibility and structure symmetry on gradient echo MR signal formation.Magnetic susceptibility induced white matter MR signal frequency shifts--experimental comparison between Lorentzian sphere and generalized Lorentzian approachesA torque balance measurement of anisotropy of the magnetic susceptibility in white matter[Ultrahigh field MRI in context of neurological diseases].Advanced MRI and staging of multiple sclerosis lesionsQuantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker.Multiple sclerosis lesion geometry in quantitative susceptibility mapping (QSM) and phase imaging.The role of iron in brain ageing and neurodegenerative disorders.Detection of demyelination in multiple sclerosis by analysis of [Formula: see text] relaxation at 7 TSimultaneous multi-angular relaxometry of tissue with MRI (SMART MRI): Theoretical background and proof of concept.Overview of quantitative susceptibility mapping.Detection of cortical lesions in multiple sclerosis: A new imaging approach.Sphere of Lorentz and demagnetization factors in white matter.7 Tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis.Quantitative susceptibility mapping of multiple sclerosis lesions at various ages.A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple scleroMagnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration.Contributions to magnetic susceptibility of brain tissue.Studying brain microstructure with magnetic susceptibility contrast at high-field.The larmor frequency shift in magnetically heterogeneous media depends on their mesoscopic structure.Subcomponents of brain T2* relaxation in schizophrenia, bipolar disorder and siblings: A Gradient Echo Plural Contrast Imaging (GEPCI) study.Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions.Lesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple Sclerosis Severity.Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation.Integrated Laplacian-based phase unwrapping and background phase removal for quantitative susceptibility mappingDiffusion lung imaging with hyperpolarized gas MRI.Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM)Susceptibility-sensitive MRI of multiple sclerosis lesions and the impact of normal-appearing white matter changes.Exploring the origins of echo-time-dependent quantitative susceptibility mapping (QSM) measurements in healthy tissue and cerebral microbleeds.Effects of biological tissue structural anisotropy and anisotropy of magnetic susceptibility on the gradient echo MRI signal phase: theoretical background.Quantitative Susceptibility Mapping Using Structural Feature Based Collaborative Reconstruction (SFCR) in the Human Brain.Chronic T2 Lesions in Multiple Sclerosis are Heterogeneous Regarding Phase MR Imaging.Voxel spread function method for correction of magnetic field inhomogeneity effects in quantitative gradient-echo-based MRI.A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field.Generalized Lorentzian Tensor Approach (GLTA) as a biophysical background for quantitative susceptibility mapping.Magnetic susceptibility to measure total protein concentration from NMR metabolite spectra: Demonstration on blood plasma.
P2860
Q22065276-B1A2C6FB-06ED-4B00-A0D7-FFD693F8CF48Q26771174-FC49240B-893C-43D9-8207-74C16B221E26Q30555643-F12C1741-7EA5-4C13-A1B8-08B99A11A028Q30586998-0E4B9A36-EFDF-486A-ABF0-CC0F4E789B6AQ30620798-AA08EFE7-8CAA-433E-BE15-98531F59605EQ30650526-F3109B8D-68E6-433E-BA71-40FA1A8F5C26Q30759627-BF38C381-8364-4B26-A62D-D6F37BA848F7Q30825494-5778C578-BEE9-4183-B47C-C23F50B84D22Q30837513-593ADCD1-6D50-46AD-ABBB-BE521B370B09Q30846734-E66A6323-CA26-4F1C-A628-4592E70C2733Q30852753-ED7714C0-E02E-4A63-B8F1-C199A7535119Q31027243-3B2A609D-F363-4F3C-8F01-FABB60449667Q31060586-06D62708-06F6-4D02-A197-DB6ABF0109D9Q31115799-FB67FEB1-F855-4B0A-8AF0-FEA6F7EAA7CEQ33692785-77FC645C-38A2-40CA-8E03-1A570440632BQ33774240-C3491E81-D122-4943-9DDA-A03ED8C929C6Q34323147-D118B71A-7666-4788-8BF3-A330269D5212Q34681059-A06F3875-B3E9-4A44-962E-1C6D5F95C08FQ35168612-5C07E24A-6713-4E95-8B8C-9D2B1F578709Q35694584-4BD4812D-1CD6-4AB2-B54F-395FF467159BQ36033901-102FA88C-EED9-4F4D-B032-BB97057D12E1Q36292407-1F87E5DE-22F9-4AD4-AEEF-3C6C18FA667BQ36376393-68191019-4F91-4AC2-A6EC-CD9EBF99F9A9Q36378141-A324991E-B9B7-485C-803C-A3BD7473F924Q37004557-A88B1B1B-E3BE-4EA1-A84E-CFF368583E8DQ37042300-E2481F00-7C2B-4B48-A6D8-4EBB2219E639Q37172391-30B43E9B-4D52-47D7-8637-85595043598AQ37246750-E7D55408-493A-40A1-8DE7-24FC7AA3F836Q37626471-D4B05494-D2C0-47EC-88F0-97FFD134B8FAQ38671539-B0C283CA-9515-428B-AC9A-E9C6BB23647EQ38708148-CBF39CFC-FE2E-4AFB-A275-A1403B76AEC3Q38805507-70D8DCCA-2081-43AA-98D8-E09273FA7766Q38996706-2D5A403E-DDF1-4CF1-8D14-0A8BBDA6D98DQ39013026-CC78E705-47D5-4E9C-8F10-54BA1AAA176BQ40976235-FB34923D-AE44-43A6-80B5-3C548AE3D9EFQ41038171-5560F992-3DFD-418D-B5D9-FA9C3459CC80Q42135037-7CCB6ADA-14EF-4D43-A360-8C3EF4EFE21DQ42573864-45FDEFF7-85AB-4F96-852A-19E40335C0B7Q43127837-BCA7B9E6-19E3-4202-8AC8-8CFFA4B712F6Q45899917-A630C96A-E26A-4C5E-BDBA-73427DAB4B47
P2860
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis
@ast
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis
@en
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis
@en-gb
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis
@nl
type
label
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis
@ast
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis
@en
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis
@en-gb
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis
@nl
prefLabel
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis
@ast
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis
@en
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis
@en-gb
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis
@nl
P2093
P2860
P3181
P356
P1476
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis
@en
P2093
Aditi Iyer
Alexander L Sukstanskii
P2860
P304
14212-14217
P3181
P356
10.1073/PNAS.1206037109
P407
P577
2012-08-13T00:00:00Z